Hypercoagulopathy in Overweight and Obese COVID-19 Patients: A Single-Center Case Series

  • Azza Sarfraz
  • , Zouina Sarfraz
  • , Aman Siddiqui
  • , Ali Totonchian
  • , Syed Hashim Abbas Ali Bokhari
  • , Hafiza Hussain
  • , Muzna Sarfraz
  • , Gaurav Patel
  • , Muhammad Hassaan Amjad
  • , Sameer Saleem Tebha
  • , Ivan Cherrez-Ojeda
  • , Patrick Dreyer
  • , Harshad Amin
  • , Jack Michel

Research output: Contribution to journalArticlepeer-review

4 Scopus citations

Abstract

A case series is presented of five overweight or obese patients with confirmed coronavirus disease 2019 (COVID-19) in South Miami, Florida, United States. A multitude of coagulation parameters was suggestive of a hypercoagulable state among the hospitalized COVID-19 patients. This article reports various manifestations of hypercoagulable states in overweight and obese patients, such as overt bleeding consistent with disseminated intravascular coagulation, venous thromboembolism, gastrointestinal bleeding as well as retroperitoneal hematoma. All of the required admission to the intensive care unit and subsequently patients died. The characteristics of COVID-19-associated coagulopathy are atypical and warrant a further understanding of the pathophysiology to improve clinical outcomes, specifically in overweight or obese patients.

Original languageEnglish
Pages (from-to)41-48
Number of pages8
JournalJournal of Critical Care Medicine
Volume8
Issue number1
DOIs
StatePublished - 1 Jan 2022

Keywords

  • Coronavirus disease 2019
  • D-dimer
  • covid-19-associated coagulopathy
  • disseminated intravascular coagulation
  • heparin
  • obesity
  • venous thromboembolism

Fingerprint

Dive into the research topics of 'Hypercoagulopathy in Overweight and Obese COVID-19 Patients: A Single-Center Case Series'. Together they form a unique fingerprint.

Cite this